Literature DB >> 18695130

Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.

Josep M Llovet, Anna Lok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18695130      PMCID： PMC2720710          DOI： 10.1093/jnci/djn261

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  34 in total

Review 1.  The challenge of developing a vaccine against hepatitis C virus.

Authors:  Xavier Forns; Jens Bukh; Robert H Purcell
Journal:  J Hepatol       Date:  2002-11       Impact factor: 25.083

Review 2.  TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.

Authors:  S P Hussain; J Schwank; F Staib; X W Wang; C C Harris
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

3.  Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.

Authors:  Savino Bruno; Tommaso Stroffolini; Massimo Colombo; Simona Bollani; Luisa Benvegnù; Giuseppe Mazzella; Antonio Ascione; Teresa Santantonio; Felice Piccinino; Pietro Andreone; Alessandra Mangia; Giovanni B Gaeta; Marcello Persico; Stefano Fagiuoli; Piero L Almasio
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Sheng-Nan Lu; Yun-Fan Liaw; San-Lin You; Chien-An Sun; Li-Yu Wang; Chuhsing K Hsiao; Pei-Jer Chen; Ding-Shinn Chen; Chien-Jen Chen
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

5.  Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Bart J Veldt; E Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen; W Peter Hofmann; Stefan Zeuzem; Michael P Manns; Bettina E Hansen; Solko W Schalm; Harry L A Janssen
Journal:  Ann Intern Med       Date:  2007-11-20       Impact factor: 25.391

Review 6.  Management of hepatitis B: summary of a clinical research workshop.

Authors:  Jay H Hoofnagle; Edward Doo; T Jake Liang; Russell Fleischer; Anna S F Lok
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

7.  Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

Authors:  Chi-Jen Chu; Munira Hussain; Anna S F Lok
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

Review 8.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

9.  Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope.

Authors:  Silvina Laura Malmassari; Qiang Deng; Hélène Fontaine; Dianne Houitte; François Rimlinger; Valérie Thiers; Bernard Maillere; Stanislas Pol; Marie-Louise Michel
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425

10.  Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.

Authors:  Y-C Chou; M-W Yu; C-F Wu; S-Y Yang; C-L Lin; C-J Liu; W-L Shih; P-J Chen; Y-F Liaw; C-J Chen
Journal:  Gut       Date:  2007-05-14       Impact factor: 23.059
View more
  7 in total

Review 1.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 2.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.

Authors:  Augusto Villanueva; Beatriz Minguez; Alejandro Forner; Maria Reig; Josep M Llovet
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

Review 3.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

Review 4.  Non-Coding RNAs in Primary Liver Cancer.

Authors:  Michele Ghidini; Chiara Braconi
Journal:  Front Med (Lausanne)       Date:  2015-06-04

5.  The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

Authors:  Yaojun Zhang; Junting Huang; Jinbin Chen; Keli Yang; Jiancong Chen; Li Xu; Zhongguo Zhou; Minshan Chen
Journal:  Cancer Manag Res       Date:  2018-03-27       Impact factor: 3.989

6.  ncRNA-disease association prediction based on sequence information and tripartite network.

Authors:  Takuya Mori; Hayliang Ngouv; Morihiro Hayashida; Tatsuya Akutsu; Jose C Nacher
Journal:  BMC Syst Biol       Date:  2018-04-11

7.  Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.

Authors:  Linlin Yan; Henghui Zhang; Hui Ma; Di Liu; Wei Li; Yulin Kang; Ruifeng Yang; Jianghua Wang; Gaixia He; Xingwang Xie; Hao Wang; Lai Wei; Zuhong Lu; Qixiang Shao; Hongsong Chen
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.